<DOC>
	<DOCNO>NCT01049672</DOCNO>
	<brief_summary>OBJECTIVES : How Alfentanil compare standard drug Diamorphine subcutaneous analgesia palliative care set ? STUDY DESIGN : An open-label pilot comparison alfentanil diamorphine palliative care patient require subcutaneous opioids .</brief_summary>
	<brief_title>Diamorphine Alfentanil Subcutaneous Use Hospice In-patients ?</brief_title>
	<detailed_description>STUDY DESIGN Study 1 - Open Label Pilot Day - 1 Hospice in-patients think clinician need subcutaneous strong opioids ask wish take part study . They give patient information leaflet 'cooling period ' ( minimum 1 day ) think . If clinician feel strong parenteral opioids need diamorphine commence immediately ( standard practice ) . Day 0 If patient agrees take part trial ask complete consent form store patient 's note . The following assessment perform : 1 . McGill Pain Questionnaire Short Form ( MPQ-SF ) 2 . Brief Pain Inventory Short Form ( BPI-SF ) These measure recommend EAPC Expert Working Group pain syndrome characterization 3 . Memorial Delirium Assessment Scale ( MDAS ) . This validated advanced cancer population use recently hospice in-patients . 4 . Nausea Visual Analogue Scale ( VAS ) 5 . Nausea Duration last 24 hour 6 . Number vomit previous 24 hour Randomisation Once baseline measure complete participant randomise use next available series number , opaque , seal envelope . These prepared remotely . Blocking used prevent imbalance term number allocate group . Block size appropriate size study divulge investigator responsible consent reveal allocation . This reduce risk investigator anticipate allocation particular patient . A study log keep site participant detail complete envelope open . Subsequent Days On subsequent day follow assessment perform : 1 . BPI-SF 2 . MDAS 3 . Nausea VAS 4 . Number vomit previous 24 hour In addition follow measurement take : 5 . Stool chart previous 24 hour 6 . Breakthrough medication ( number dose dosage ) use 7 . Laxatives take 8 . Other change medication Patients cease participation assessment day 7 .</detailed_description>
	<mesh_term>Heroin</mesh_term>
	<mesh_term>Alfentanil</mesh_term>
	<criteria>1 . To think hospice doctor require parenteral strong opioids . 2 . To estimate prognosis less 1 year . 1 . Inability read English sufficiently able complete assessment questionnaire . 2 . Confusion sufficient patient unable complete questionnaire . 3 . Weakness fatigue sufficient patient unable complete questionnaire . 4 . Radiotherapy source pain last 4 week . 5 . Change corticosteroid dose last week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>